Cita APA (7th ed.)

Domingo, E., Camps, C., Kaisaki, P., Parsons, M., Mouradov, D., Pentony, M., . . . Tomlinson, I. (2018). Mutation burden and other molecular markers of prognosis in the QUASAR2 clinical trial of colorectal cancer treated with curative intent. Elsevier.

Cita Chicago (17th ed.)

Domingo, E., et al. Mutation Burden and Other Molecular Markers of Prognosis in the QUASAR2 Clinical Trial of Colorectal Cancer Treated with Curative Intent. Elsevier, 2018.

Cita MLA (9th ed.)

Domingo, E., et al. Mutation Burden and Other Molecular Markers of Prognosis in the QUASAR2 Clinical Trial of Colorectal Cancer Treated with Curative Intent. Elsevier, 2018.